GOTx, standing apart in a crowded ADC market https://lnkd.in/etUvc_bD
GO Therapeutics
生物技术研究
Natick，Massachusetts 945 位关注者
Opening the Therapeutic Window for antibody-based cancer therapies
关于我们
GO Therapeutics is exploiting unique aspects of cancer cell biology to develop a new class of cancer therapies for previously intractable solid tumors. We target O-linked glycoproteins specific to cancer cells to develop proprietary, high-affinity antibodies to novel cancer-specific targets. Our antibodies are the basis for a broad array of potent cancer-killing modalities including T-cell bispecifics (TCBs), CAR-T, and antibody drug conjugates (ADCs). Each are designed to kill cancer while sparing healthy tissue.
- 网站
-
https://www.gotherapeutics.com
GO Therapeutics的外部链接
- 所属行业
- 生物技术研究
- 规模
- 2-10 人
- 总部
- Natick，Massachusetts
- 类型
- 私人持股
- 创立
- 2014
- 领域
- Drug development、Antigen development、Antobody developement、O-glycosylation、Glycoproteomics、Glycopeptides和Cellular engineering
地点
GO Therapeutics员工
动态
-
GOTx, standing apart in a crowded ADC market https://lnkd.in/etUvc_bD
Era of ADCs: Pharma companies innovate to stand out in a buzzing market - Pharma Technology Focus | Issue 146 | September 2024
pharma.h5mag.com
-
Great work by you and Image Conscious Studios. It is a real treat to work with highly talented professionals at the top of their game, and I think the end product reflects this well. If you are the biotech space and want to uplift your visual ID and story, I highly recommend ICS and Michael to help get you there.
GO Therapeutics identifies super clean tumors and targets - meaning fewer adverse events and patient intolerabilities. Big shout out to my team for developing a powerful brand platform for them to tell their incredible story. Image Conscious Studios Go team; Danielle Sharples, Katie Bumatay, Justin Perricone, Adam Riggs, Ryan Sherwood, PMP, Stefanie G, and Michael Haas for developing the copy.
-
GO will be presenting a poster on our novel glycoprotein tumor targeting ADCs at #AACR24. We hope that these next generation ADCs will pave the way for more efficacious and less toxic cancer therapies.
-
-
GO will be presenting a poster on our novel glycoprotein tumor targeting ADCs at #AACR24. We hope that these next generation ADCs will pave the way for more efficacious and less toxic cancer therapies.
-